Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2015 2
2016 3
2017 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
MicroRNAs targeting EGFR signalling pathway in colorectal cancer.
Mlcochova J, Faltejskova P, Nemecek R, Svoboda M, Slaby O. Mlcochova J, et al. J Cancer Res Clin Oncol. 2013 Oct;139(10):1615-24. doi: 10.1007/s00432-013-1470-9. Epub 2013 Jul 2. J Cancer Res Clin Oncol. 2013. PMID: 23817698 Review.
A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
Valianatos G, Valcikova B, Growkova K, Verlande A, Mlcochova J, Radova L, Stetkova M, Vyhnakova M, Slaby O, Uldrijan S. Valianatos G, et al. Among authors: mlcochova j. PLoS One. 2017 Oct 3;12(10):e0185801. doi: 10.1371/journal.pone.0185801. eCollection 2017. PLoS One. 2017. PMID: 28973015 Free PMC article.
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients.
Kiss I, Mlcochova J, Bortlicek Z, Poprach A, Drabek J, Vychytilova-Faltejskova P, Svoboda M, Buchler T, Batko S, Ryska A, Hajduch M, Slaby O. Kiss I, et al. Among authors: mlcochova j. Anticancer Res. 2016 Sep;36(9):4955-9. doi: 10.21873/anticanres.11063. Anticancer Res. 2016. PMID: 27630355 Clinical Trial.